FYSIOPRIM Cohort: Physiotherapy Use and Outcomes in Musculoskeletal Disorders

A cohort study of 671 patients with musculoskeletal disorders links physiotherapy contact frequency to clinical outcomes and future healthcare costs. The dataset combines clinical data from the FYSIOPRIM primary care cohort with national registry data on healthcare use and socioeconomic factors. Olav Amundsen published the study on figshare in May 2026.

Use Cases

• Analyze associations between physiotherapy contact frequency and Global Perceived Effect (GPE) based on clinical prognosis groups.
• Model the relationship between clinical improvement and future high healthcare costs or disability pension risk.
• Evaluate resource allocation efficiency by tailoring treatment intensity to patient prognosis.

Strengths

• Dataset includes 671 patients with complete 12-month follow-up data.
• Links clinical cohort data with national registry data on healthcare costs and socioeconomic outcomes.
• Analysis categorizes patients into good, medium, and poor prognosis groups based on seven baseline clinical factors.

Limitations

• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• Data may reflect geographic/temporal bias inherent to the source cohort.

Provenance

Source

FYSIOPRIM primary care physiotherapy cohort and national registries.

Collection Method

Cohort study linking clinical and registry data.

Time Range

12-month clinical follow-up, with registry data covering 1-3 years post-FYSIOPRIM.

Freshness

Last updated 2026-05-05 07:20:03; freshness should be verified.